Research

Presentations

Our models are developed and reviewed with academic vascular surgeons, and the results are presented at the meetings they attend.

Rapid-fire paper

October 2026

Development of a Risk Prevention Model for Intervention in Acute Type B Aortic Dissection

New England Society for Vascular Surgery, 53rd Annual Meeting

Doulamis I, Overtchouk P, Fernandes L, Khan S, Graves J, Lipsitz E, Makoid J, Indes J

With Lahey Hospital & Medical Center · Montefiore Medical Center · UMass Chan Medical School

E-poster

September 2026

Machine Learning Prediction of Renal Malperfusion After Acute Type B Aortic Dissection

Midwestern Vascular Surgical Society, 2026 Annual Meeting

Khan S, Overtchouk P, Makoid J, Graves J, Milner R

With The University of Chicago Medicine

Collaborators

Pipeline

AortaNavigator

AAA, TBAD, TAA surveillance and care gaps

Available today for health system pilots.

Development

Retrospective validation

Health system pilots

Current

Deployment

Pythia for AAA

Abdominal aortic aneurysm

First FDA submission.

Model development

Retrospective validation

FDA Pre-Submission

Multi-site validation

Current

510(k) submission

Pythia for TBAD

Type B aortic dissection

Follows AAA as a second submission.

Model development

Retrospective validation

Current

FDA Pre-Submission

Multi-site validation

510(k) submission

Pythia is in development and has not been cleared or approved by the FDA. It is not available for clinical use.